Essink, Sharon C. M. http://orcid.org/0000-0003-2079-4816
Zomerdijk, Inge M.
Straus, Sabine M. J. M.
Gardarsdottir, Helga http://orcid.org/0000-0001-5623-9684
De Bruin, Marie L. http://orcid.org/0000-0001-9197-7068
Funding for this research was provided by:
College ter Beoordeling van Geneesmiddelen
Article History
Accepted: 26 July 2023
First Online: 2 September 2023
Declarations
:
: This research was funded with a grant from the Dutch Medicines Evaluation Board (MEB), as part of the regulatory science collaboration between the MEB and Utrecht University.
: Sharon C.M. Essink, Inge M. Zomerdijk, Sabine M.J.M. Straus, Helga Gardarsdottir, and Marie L. De Bruin declare that they have no conflict of interest for this work.
: Not applicable as no human subjects/data are involved.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are not openly available due to reasons of confidentiality and are available on aggregated level from the corresponding author upon reasonable request. Data are located in controlled access data storage at the Medicines Evaluation Board.
: Data are analysed using Microsoft Excel, SPSS version 28.0.1.1, and R version 4.1.2. Codes are available, together with data on aggregated level, from the corresponding author upon reasonable request.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Sharon C.M. Essink, Inge M. Zomerdijk and discussed with and checked by Sabine M.J.M. Straus, Helga Gardarsdottir, and Marie L. De Bruin. The first draft of the manuscript was written by Sharon C.M. Essink and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.